Literature DB >> 28060131

Nonfunctioning Adrenocortical Carcinoma in Pediatric Acute Lymphoblastic Leukemia: A Case Report of a Rare Multiple Primaries Combination.

Wafaa M Rashed1, Wael Zekri, Madiha Awad, Hala Taha, Badr Abdalla, Ahmad S Alfaar.   

Abstract

Childhood adrenocortical carcinoma (ACC) is a rare tumor and its association with acute lymphoblastic leukemia (ALL) is even rarer. One such case is discussed in this case report. A 3-year-old patient was concomitantly diagnosed with ALL and an initially nonmetastatic ACC. Management started by following the Total XV protocol without a window phase. Left adrenalectomy was conducted after the consolidation phase. Recurrence of a mass at the tumor bed was discovered at week 33 of the continuation phase. Reexcision was conducted, followed by the administration of an ACC protocol including cisplatin, etoposide, and doxirubicin. Mitotane was added when a pulmonary metastasis was discovered and then stopped after the patient suffered from an arachnoid cyst and speech difficulties. The ALL protocol was resumed from week 34 of the continuation phase. Progression of pulmonary nodules was noted after week 45. A pulmonary metastectomy was performed. The ALL protocol was resumed up to week 51 with a good response as proven by assessment of minimal residual disease. A further recurrence was diagnosed at the abdominal tumor bed with a paravertebral mass and a pulmonary nodule. The patient was assigned to palliative treatment and died after a 32-month survival. Such rare associations need more extensive discussions of the best possible management in scientific literature.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28060131     DOI: 10.1097/MPH.0000000000000699

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  2 in total

1.  Incidence of adrenal gland tumor as a second primary malignancy: SEER-based study.

Authors:  Wafaa M Rashed; Anas M Saad; Muneer J Al-Husseini; Ahmed Mahmoud Galal; Assem Mohamed Ismael; Ahmed M Al-Tayep; Ayman El Shafie; Mahmoud Ahmed Ali; Ahmed Samir Alfaar
Journal:  Endocr Connect       Date:  2018-08-23       Impact factor: 3.335

Review 2.  EDP-mitotane in children: reassuring evidence of reversible side-effects and neurotoxicity.

Authors:  Rebecca V Steenaard; Marieke Rutjens; Madeleine H T Ettaieb; Max M van Noesel; Harm R Haak
Journal:  Discov Oncol       Date:  2022-04-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.